✦ LIBER ✦

Enhanced platelet reactivity and hypercoagulability in the steady state of sickle cell anaemia

✍ Scribed by Dr. S. I. Berney; C. D. Ridler; A. D. Stephens; A. E. Thomas; I. B. Kovacs

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 398 KB
Volume: 40
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830400409

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The number of people with sickle-cell di

The number of people with sickle-cell disease in the United States: national and state estimates

✍ David C. Brousseau; Julie A Panepinto; Mark Nimmer; Raymond G Hoffmann 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB 👁 2 views

Sickle-cell disease is not a reportable condition, making it difficult to ascertain the number of affected individuals. We estimated the number of people with sickle-cell disease for the United States and each individual state, adjusting for increased mortality. US Census population data for each of

Molecular characterization of sickle cel

Molecular characterization of sickle cell anemia in the Northern Brazilian state of Pará

✍ Greice De Lemos Cardoso; João Farias Guerreiro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract To assess α+‐thalassemia deletion alleles, β‐thalassemia mutations and haplotypes linked to the HBB\*S cluster in a sample of 130 unrelated sickle cell anemia (SCA) patients (55% female) from Belém, Pará State, for their possible effects on the patients' survival. ‐α^3.7^, ‐α^42^, ‐α^20

Blood samples collected under venous oxy

Blood samples collected under venous oxygen pressure from patients with sickle cell disease contain a significant number of a new type of reversibly sickled cells: Constancy of the percentage of sickled cells in individual patients during steady state

✍ Toshio Asakura; Kenji Asakura; Kazuo Obata; Julian Mattiello; Samir K. Ballas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 2 views

Hospitalization rates and costs of care

Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea

✍ Sophie Lanzkron; Carlton Haywood Jr; Jodi B. Segal; George J. Dover 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract The multicenter study of hydroxyurea (MSH) in sickle‐cell anemia (SCA) demonstrated that patients treated with hydroxyurea (HU) had a 44% decrease in hospitalizations when compared with those taking placebo. A subsequent study looking at the cost‐effectiveness of HU showed that decrease

Sickle cell disease in the United States

Sickle cell disease in the United States: Looking back and forward at 100 years of progress in management and survival

✍ Hari Prabhakar; Carlton Haywood Jr.; Robert Molokie 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

## Abstract The past 100 years since James Herrick's first description of sickle cell disease in the United States have been characterized by the gradual development of management strategies. We review the progress in sickle cell disease management in the United States over the past 100 years, with

Phosphatidylserine in the outer leaflet

Phosphatidylserine in the outer leaflet of red blood cells from β-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes

✍ Vered Borenstain-Ben Yashar; Yechezkel Barenholz; Esther Hy-Am; Eliezer A. Rachm 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 1 views